Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1995 3
1996 2
1997 2
1998 2
1999 3
2000 1
2002 2
2003 1
2006 3
2007 5
2008 3
2009 2
2010 4
2011 2
2012 5
2013 6
2014 5
2015 3
2016 2
2017 1
2018 3
2019 4
2020 10
2021 17
2022 23
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
Deal CL, Steelman J, Vlachopapadopoulou E, Stawerska R, Silverman LA, Phillip M, Kim HS, Ko C, Malievskiy O, Cara JF, Roland CL, Taylor CT, Valluri SR, Wajnrajch MP, Pastrak A, Miller BS. Deal CL, et al. Among authors: valluri sr. J Clin Endocrinol Metab. 2022 Jun 16;107(7):e2717-e2728. doi: 10.1210/clinem/dgac220. J Clin Endocrinol Metab. 2022. PMID: 35405011 Free PMC article. Clinical Trial.
Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.
Martin T, Usmani SZ, Schecter JM, Vogel M, Jackson CC, Deraedt W, Tian H, Yeh TM, Banerjee A, Pacaud L, Garrett A, Haltner A, Cameron C, Van Sanden S, Diels J, Valluri S, Samjoo IA. Martin T, et al. Among authors: valluri s. Curr Med Res Opin. 2021 Oct;37(10):1779-1788. doi: 10.1080/03007995.2021.1953456. Epub 2021 Jul 23. Curr Med Res Opin. 2021. PMID: 34256668 Clinical Trial.
An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment.
Zadik Z, Zelinska N, Iotova V, Skorodok Y, Malievsky O, Mauras N, Valluri SR, Pastrak A, Rosenfeld R. Zadik Z, et al. Among authors: valluri sr. J Pediatr Endocrinol Metab. 2023 Feb 3;36(3):261-269. doi: 10.1515/jpem-2022-0359. Print 2023 Mar 28. J Pediatr Endocrinol Metab. 2023. PMID: 36732285 Free article. Clinical Trial.
Opportunities and challenges in CO2 utilization.
Valluri S, Claremboux V, Kawatra S. Valluri S, et al. J Environ Sci (China). 2022 Mar;113:322-344. doi: 10.1016/j.jes.2021.05.043. Epub 2021 Jul 6. J Environ Sci (China). 2022. PMID: 34963541 Review.
The burden of non-radiographic axial spondyloarthritis.
Boonen A, Sieper J, van der Heijde D, Dougados M, Bukowski JF, Valluri S, Vlahos B, Kotak S. Boonen A, et al. Among authors: valluri s. Semin Arthritis Rheum. 2015 Apr;44(5):556-562. doi: 10.1016/j.semarthrit.2014.10.009. Epub 2014 Oct 22. Semin Arthritis Rheum. 2015. PMID: 25532945 Review.
Drug-induced uveitis.
Moorthy RS, Valluri S, Jampol LM. Moorthy RS, et al. Among authors: valluri s. Surv Ophthalmol. 1998 May-Jun;42(6):557-70. doi: 10.1016/s0039-6257(97)00130-6. Surv Ophthalmol. 1998. PMID: 9635904 Review.
Retrobulbar anesthesia.
Moorthy SS, Valluri S, Cummings L. Moorthy SS, et al. Among authors: valluri s. Ophthalmology. 2002 Jan;109(1):5-6. doi: 10.1016/s0161-6420(01)00911-3. Ophthalmology. 2002. PMID: 11772567 No abstract available.
Nontuberculous mycobacterial ocular and adnexal infections.
Moorthy RS, Valluri S, Rao NA. Moorthy RS, et al. Among authors: valluri s. Surv Ophthalmol. 2012 May-Jun;57(3):202-35. doi: 10.1016/j.survophthal.2011.10.006. Surv Ophthalmol. 2012. PMID: 22516536 Review.
Matching-Adjusted Indirect Treatment Comparison to Assess the Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 Versus Belantamab Mafodotin in DREAMM-2, Selinexor-Dexamethasone in STORM Part 2, and Melphalan Flufenamide-Dexamethasone in HORIZON for the Treatment of Patients With Triple-Class Exposed Relapsed or Refractory Multiple Myeloma.
Weisel K, Krishnan A, Schecter JM, Vogel M, Jackson CC, Deraedt W, Yeh TM, Banerjee A, Yalniz F, Nesheiwat T, Van Sanden S, Diels J, Valluri S, Usmani SZ, Berdeja JG, Jagannath S, Martin T. Weisel K, et al. Among authors: valluri s. Clin Lymphoma Myeloma Leuk. 2022 Sep;22(9):690-701. doi: 10.1016/j.clml.2022.04.025. Epub 2022 May 23. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35764490 Free article. Clinical Trial.
114 results